Definition, Diagnostic Criteria & Classification

Question	Answer
1. Detail the WHO (2009) / NVBDCP Classification of Dengue Infection.	The classification stratifies dengue into three clinical categories: 1) Dengue without Warning Signs: Acute febrile illness with $\ge 2$ of: nausea/vomiting, rash, aches and pains (headache, retro-orbital pain, myalgia, arthralgia), positive tourniquet test, leukopenia. 2) Dengue with Warning Signs: Dengue fever accompanied by any of: - Abdominal pain or tenderness. - Persistent vomiting ($\ge 3$ episodes in 24h or unable to tolerate oral fluids). - Clinical fluid accumulation (pleural effusion, ascites). - Mucosal bleeding (epistaxis, gingival, hematemesis, melena). - Lethargy, restlessness, or behavioral change. - Hepatomegaly $> 2\text{ cm}$ below right costal margin. - Laboratory: Progressive increase in Hematocrit concurrent with rapid decline in platelet count. 3) Severe Dengue: Dengue with at least one of: - Severe Plasma Leakage: Leading to Shock (Dengue Shock Syndrome - DSS) or fluid accumulation with respiratory distress. - Severe Bleeding: As evaluated by clinician (massive GI bleeding, pulmonary hemorrhage). - Severe Organ Impairment: Liver (AST or ALT $\ge 1000\text{ U/L}$), CNS (impaired consciousness), Heart (myocarditis), or Kidneys (AKI).
2. How is Dengue Shock Syndrome (DSS) classified hemodynamically?	Stratified into two stages based on blood pressure and perfusion: 1) Compensated Shock: Normal systolic blood pressure maintained by intense peripheral vasoconstriction, but with signs of hypoperfusion: tachycardia, cool clammy peripheries, delayed capillary refill time ($>2\text{ seconds}$), weak/thready peripheral pulses, and narrowed pulse pressure ($\le 20\text{ mmHg}$) (e.g., BP $90/74\text{ mmHg}$). 2) Decompensated (Hypotensive) Shock: Frank systolic hypotension below the 5th percentile for age: - Infant ($<1\text{ year}$): Systolic $\text{BP} < 70\text{ mmHg}$. - $1\text{ to } 10\text{ years}$: Systolic $\text{BP} < 70 + (2 \times \text{age in years})\text{ mmHg}$. - $>10\text{ years}$: Systolic $\text{BP} < 90\text{ mmHg}$. - Child appears lethargic or comatose with undetectable peripheral pulses.
3. What is the "Critical Phase" of Dengue, and when does it occur?	- Timeline: Occurs between Day 3 and Day 7 of illness, characteristically coinciding precisely with defervescence (temperature dropping to $37.5-38^\circ\text{C}$ or normal). - Pathological Hallmark: Onset of systemic capillary hyperpermeability and plasma leakage lasting 24 to 48 hours. - Clinical Importance: Many parents and inexperienced clinicians mistakenly assume the child is recovering because the fever has subsided, whereas the child is entering the most dangerous phase where fatal shock can develop within hours!
4. What are the diagnostic laboratory tests for Dengue, and how are they interpreted based on timing?	- Days 1 to 5 (Viremic Phase): 1) Dengue NS1 Antigen: Non-structural protein 1 secreted into blood; highly specific ($>95\%$) and sensitive in first 5 days. 2) RT-PCR: Confirms dengue serotype (DENV-1 to 4); gold standard for viremia. - Day 5 onwards (Convalescent / Serological Phase): 1) Dengue IgM ELISA: Detectable from day 4-5, peaks around day 14; establishes acute infection. 2) Dengue IgG ELISA: In primary infection, rises slowly after day 10. In secondary dengue, IgG levels are already sky-high in the acute phase (high IgG/IgM ratio $>1.1$).
5. VIVA TRAP: A child with dengue has a platelet count of 12,000/uL but is hemodynamically stable with no active bleeding. Should you transfuse platelets?	NO, EMPHATICALLY NO. Prophylactic platelet transfusion in dengue is STRONGLY CONTRAINDICATED regardless of how low the platelet count drops! Proven by multiple international randomized trials (e.g., ADAPT trial): 1) Prophylactic platelets do NOT prevent severe bleeding. 2) They do NOT accelerate platelet count recovery. 3) They significantly increase hospital stay, adverse transfusion reactions, TRALI, and fatal fluid overload / pulmonary edema during the critical plasma leak phase! Indications for platelets: Only in severe, life-threatening overt clinical hemorrhage (massive GI bleed) or emergency surgery.

Pathophysiology & Complications

Question	Answer
6. Explain the "Antibody-Dependent Enhancement" (ADE) hypothesis in severe secondary Dengue.	- Infection with one of the four Dengue serotypes (e.g., DENV-1) produces lifelong homotypic immunity, but only temporary cross-reactive heterotypic antibodies against the other three serotypes (DENV-2, 3, 4). - During a secondary infection with a different serotype years later, pre-existing sub-neutralizing heterotypic IgG antibodies bind to the new virions without neutralizing them. - These antibody-virus complexes bind avidly to Fc$\gamma$ receptors on monocytes and macrophages. - This facilitates massive viral entry, uncontrolled intracellular viral replication, and infected cell mass expansion. - Culminates in a violent cytokine storm (TNF-$\alpha$, IL-6, IL-8, IFN-$\gamma$) and massive release of soluble NS1 protein.
7. Detail the mechanism of capillary leakage: The Endothelial Glycocalyx disruption.	- Dengue NS1 hexamer protein binds directly to Toll-like receptor 4 (TLR4) on human endothelial cells and activates sialidases and heparanase. - This causes enzymatic cleavage and degradation of the endothelial glycocalyx layer (a meshwork of heparan sulfate and chondroitin sulfate proteoglycans covering microvascular endothelium). - Disruption of the glycocalyx uncovers tight junction pores and reverses the oncotic filtration gradient. - Massive transudation of albumin-rich plasma occurs into the extravascular interstitial space (pleural cavity, peritoneal space, retroperitoneum), causing profound hypovolemia, hemoconcentration (Hematocrit spike $\ge 20\%$), and hypotension.
8. What are the clinical and physiological consequences of "Fluid Overload" in Dengue?	- Occurs when excessive or prolonged IV fluids are administered during the critical phase, or when IV fluids are not rapidly tapered during the Recovery Phase (when leaked plasma is naturally reabsorbed into the intravascular space). - Manifestations: Respiratory distress, tachypnea, severe bilateral pleural effusions, tense ascites, periorbital edema, pulmonary edema, pink frothy sputum, and secondary congestive heart failure. - VIVA TRAP: In recovery phase, hematocrit drops due to physiological auto-expansion of plasma volume; mistaking this dilutional drop for ongoing occult bleeding and transfusing blood causes fatal pulmonary edema!

Guidelines & Management Protocols (WHO & National Guidelines)

Question	Answer
9. Detail the fluid resuscitation protocol for Compensated Dengue Shock.	1) Initial Bolus: Infuse Isotonic Crystalloid (0.9% Normal Saline or Ringer's Lactate) at $10\text{ to } 20\text{ mL/kg}$ over 1 hour. 2) Reassessment at 1 hour: - If child improves (pulse pressure $>20\text{ mmHg}$, HR normalizing, CRT $<2\text{ s}$, urine output $>1\text{ mL/kg/hr}$, Hct decreasing): - Reduce fluid to $5-7\text{ mL/kg/hr}$ for 2-4 hours. - Further reduce to $3-5\text{ mL/kg/hr}$ for 2-4 hours, then $2-3\text{ mL/kg/hr}$ for 24-48 hours. - Stop IV fluids completely at 48 hours after defervescence! - If child remains unstable with high Hct: Repeat second bolus of isotonic crystalloid $10-20\text{ mL/kg}$ over 1 hour. If still refractory, switch to Colloid (10% Dextran-40 or 6% Hetastarch) at $10-20\text{ mL/kg}$ over 1 hour.
10. Detail the emergency management of Decompensated (Hypotensive) Dengue Shock.	1) Emergency Resuscitation: - Give $20\text{ mL/kg}$ Isotonic Crystalloid as a rapid push over 15 minutes. 2) Reassessment at 15 minutes: - If shock resolves: Reduce to crystalloid $10\text{ mL/kg/hr}$ for 1 hour, then taper gradually as in compensated shock. - If shock persists: - Administer Colloid (Dextran-40 or 6% HES) $10\text{ to } 20\text{ mL/kg}$ over 30 to 60 minutes. - Check Hematocrit: If Hct remains high, continue colloid. If Hct drops significantly but shock persists, suspect Massive Occult Internal Hemorrhage $\to$ immediately crossmatch and transfuse Fresh Whole Blood ($20\text{ mL/kg}$) or Packed Red Cells ($10\text{ mL/kg}$)!
11. What are the strict discharge criteria for a patient recovered from Dengue?	All of the following must be satisfied: 1) Afebrile for at least 48 hours without antipyretics. 2) Significant clinical improvement, good general condition, alert, and appetite returned. 3) Stable hemodynamics and normal vital signs for $\ge 48$ hours. 4) Stable hematocrit at baseline without IV fluids. 5) At least 48 hours elapsed since recovery from shock. 6) No respiratory distress from pleural effusion or ascites. 7) Platelet count $\ge 50,000/\mu\text{L}$ AND demonstrating an upward trend.

VIVA TRAPs & Counter-Questions

Question

Answer

12. VIVA TRAP: Why are NSAIDs (Ibuprofen, Mefenamic Acid) and Aspirin strictly CONTRAINDICATED in Dengue?

1) Platelet Dysfunction: Ibuprofen and aspirin reversibly/irreversibly inhibit COX-1 and platelet thromboxane $A_2$, aggravating severe thrombocytopenia and triggering fatal gastrointestinal hemorrhage.
2) Gastric Mucosal Toxicity: Direct erosion of gastric mucosa triggers acute upper GI bleeding.
3) Reye Syndrome: Aspirin in viral infections induces encephalopathy and hepatic failure.
- Safe Alternative: Paracetamol strictly at $10-15\text{ mg/kg/dose}$ (maximum $60\text{ mg/kg/day}$), maintaining minimum 4-6 hour dosing intervals to prevent hepatotoxicity in already inflamed liver tissue!

13. Counter-Question Chain: "A child with Dengue Shock responds to crystalloid boluses initially, but 6 hours later sensorium deteriorates, BP is 80/60 mmHg, and Hematocrit plummets from 46% to 26%. What has happened and what is the immediate management?"

- Diagnosis: Severe Occult Internal Gastrointestinal Hemorrhage (often retroperitoneal or upper GI).
- Mechanism: Capillary leak plus microvascular coagulopathy and thrombocytopenia leading to massive bleeding into bowel lumen without overt hematemesis initially.
- Immediate Management:
1) Do NOT give more crystalloid boluses (worsens hemodilution and coagulopathy)!
2) Stat crossmatch and transfuse Fresh Packed Red Blood Cells ($10\text{ mL/kg}$) or Fresh Whole Blood ($20\text{ mL/kg}$).
3) Administer Fresh Frozen Plasma ($10-15\text{ mL/kg}$) if coagulopathy is present (prolonged PT/INR).
4) Administer IV Proton Pump Inhibitor (Pantoprazole $1\text{ mg/kg}$).